cisapride has been researched along with Respiratory Distress Syndrome in 1 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cisapride is a "prokinetic" agent (increases gastric emptying), that may increase the splanchnic circulation and thus favourably affect gas exchange in peritoneal ventilation." | 1.29 | Peritoneal ventilation in rabbits: augmentation of gas exchange with cisapride. ( Barr, J; Bistritzer, T; Eshel, G; Gurevitch, S; Klin, B; Lahat, E; Lushkov, G; Strauss, S, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barr, J | 1 |
| Lushkov, G | 1 |
| Strauss, S | 1 |
| Gurevitch, S | 1 |
| Lahat, E | 1 |
| Bistritzer, T | 1 |
| Klin, B | 1 |
| Eshel, G | 1 |
1 other study available for cisapride and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Peritoneal ventilation in rabbits: augmentation of gas exchange with cisapride.
Topics: Animals; Blood Flow Velocity; Carbon Dioxide; Cisapride; Cross-Over Studies; Disease Models, Animal; | 1996 |